
<!DOCTYPE article
  PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" article-type="correction" xml:lang="en"><processing-meta tagset-family="jats" base-tagset="archiving" mathml-version="3.0" table-model="xhtml"><custom-meta-group><custom-meta assigning-authority="highwire" xlink:type="simple"><meta-name>recast-jats-build</meta-name><meta-value>1d2b230b09</meta-value></custom-meta></custom-meta-group></processing-meta><front><journal-meta><journal-id journal-id-type="hwp">jitc</journal-id><journal-id journal-id-type="nlm-ta">J Immunother Cancer</journal-id><journal-id journal-id-type="publisher-id">jitc</journal-id><journal-title-group><journal-title>Journal for ImmunoTherapy of Cancer</journal-title><abbrev-journal-title abbrev-type="publisher">J Immunother Cancer</abbrev-journal-title><abbrev-journal-title>J Immunother Cancer</abbrev-journal-title></journal-title-group><issn pub-type="epub">2051-1426</issn><publisher><publisher-name>BMJ Publishing Group Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">jitc-2020-000528corr1</article-id><article-id pub-id-type="doi">10.1136/jitc-2020-000528corr1</article-id><article-id pub-id-type="pmid">32457128</article-id><article-id pub-id-type="apath" assigning-authority="highwire">/jitc/8/1/e000528corr1.atom</article-id><article-categories><subj-group subj-group-type="heading"><subject>Correction</subject></subj-group><subj-group subj-group-type="collection" assigning-authority="publisher"><subject>Open access</subject></subj-group><subj-group subj-group-type="collection" assigning-authority="highwire"><subject>Special collections</subject><subj-group><subject>Open access</subject></subj-group></subj-group></article-categories><title-group><article-title>Correction: Cell death induced by cytotoxic CD8+ T cells is immunogenic and primes caspase-3–dependent spread immunity against endogenous tumor antigens</article-title></title-group><pub-date date-type="pub" iso-8601-date="2020-05" pub-type="ppub" publication-format="print"><month>5</month><year>2020</year></pub-date><pub-date date-type="pub" iso-8601-date="2020-05-23" pub-type="epub-original" publication-format="electronic"><day>23</day><month>5</month><year>2020</year></pub-date><pub-date iso-8601-date="2019-12-20T04:54:25-08:00" pub-type="hwp-received"><day>20</day><month>12</month><year>2019</year></pub-date><pub-date iso-8601-date="2019-12-20T04:54:25-08:00" pub-type="hwp-created"><day>20</day><month>12</month><year>2019</year></pub-date><pub-date iso-8601-date="2020-05-25T21:52:06-07:00" pub-type="epub"><day>25</day><month>5</month><year>2020</year></pub-date><volume>8</volume><issue>1</issue><elocation-id>e000528corr1</elocation-id><permissions><copyright-statement>© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</copyright-statement><copyright-year>2020</copyright-year><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/" xlink:type="simple"><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2020-05-23">http://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" xlink:type="simple">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="jitc-2020-000528corr1.pdf" xlink:type="simple"/><custom-meta-group><custom-meta xlink:type="simple"><meta-name>special-feature</meta-name><meta-value>unlocked</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p>Jaime-Sanchez P, Uranga-Murillo I, Aguilo N, <italic toggle="yes">et al</italic>. Cell death induced by cytotoxic CD8<sup>+</sup> T cells is immunogenic and primes caspase-3–dependent spread immunity against endogenous tumor antigens. J Immunother Cancer 2020;8:e000528. doi: 10.1136/jitc-2020-000528</p><p>Since the online publication of this article, it was noticed that notes to production were left in the main text. These have been removed and the reference ‘Minute L, Teijeira A, Sanchez-Paulete AR, <italic toggle="yes">et al</italic>. Cellular cytotoxicity is a form of immunogenic cell death. J Immunother Cancer 2020;8:e000325. doi: 10.1136/jitc-2019-000325’ has been added to the article.</p></body></article>